Edition:
United States

UnitedHealth Group Inc (UNH.N)

UNH.N on New York Stock Exchange

195.21USD
4:02pm EDT
Change (% chg)

$-0.54 (-0.28%)
Prev Close
$195.75
Open
$195.63
Day's High
$196.10
Day's Low
$194.90
Volume
435,545
Avg. Vol
831,795
52-wk High
$200.76
52-wk Low
$133.03

Chart for

About

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum. UnitedHeal... (more)

Overall

Beta: 0.64
Market Cap(Mil.): $189,262.80
Shares Outstanding(Mil.): 966.86
Dividend: 0.75
Yield (%): 1.53

Financials

  Industry Sector
P/E (TTM): -- 22.79 16.33
EPS (TTM): -- -- --
ROI: -- 0.01 14.66
ROE: -- 15.96 13.99

Pfizer files suit against J&J over Remicade contracts

Drugmaker Pfizer Inc on Wednesday filed a lawsuit against Johnson & Johnson , saying its rival's contracts with health insurers for blockbuster rheumatoid arthritis drug, Remicade, were anticompetitive and blocked sales of Pfizer's new biosimilar.

Sep 20 2017

UPDATE 3-Pfizer files suit against J&J over Remicade contracts

Sept 20 Drugmaker Pfizer Inc on Wednesday filed a lawsuit against Johnson & Johnson, saying its rival's contracts with health insurers for blockbuster rheumatoid arthritis drug, Remicade, were anticompetitive and blocked sales of Pfizer's new biosimilar.

Sep 20 2017

Pfizer files suit against J&J over Remicade contracts

Drugmaker Pfizer Inc on Wednesday filed a lawsuit against Johnson & Johnson, saying its rival's contracts with health insurers for blockbuster rheumatoid arthritis drug, Remicade, were anticompetitive and blocked sales of Pfizer's new biosimilar.

Sep 20 2017

BRIEF-Inovalon Holdings says ‍UnitedHealthcare has entered into a 5-year engagement with co​

* Inovalon Holdings Inc - ‍UnitedHealthcare has entered into a five-year engagement with co​ Source text for Eikon: Further company coverage:

Sep 12 2017

Advisory Board to sell healthcare, education units in $2.58 billion deal

Advisory Board Co said it would sell its healthcare business to UnitedHealth Group Inc's Optum unit and education business to private equity firm Vista Equity Partners, for a total deal value of $2.58 billion.

Aug 29 2017

UPDATE 2-Advisory Board to sell healthcare, education units in $2.58 bln deal

Aug 29 Advisory Board Co said it would sell its healthcare business to UnitedHealth Group Inc's Optum unit and education business to private equity firm Vista Equity Partners, for a total deal value of $2.58 billion.

Aug 29 2017

Fitch: Profits and Deleveraging Drive Improved Credit Metrics of Health Insurers

(The following statement was released by the rating agency) Link to Fitch Ratings' Report: U.S. Health Insurance: Credit Metrics Update (First-Half 2017) https://www.fitchratings.com/site/re/902624 CHICAGO, August 28 (Fitch) Debt reductions related to unsuccessful mergers, ongoing deleveraging efforts, as well as solid earnings and equity growth were responsible for improved credit metrics reported by the eight publicly traded health insurers rated or followed by Fitch Ratings during the first h

Aug 28 2017

BRIEF-UnitedHealth Group ‍board approved a reduction in annual base salary to $1 mln for Stephen Hemsley

* UnitedHealth Group Inc says ‍board approved a reduction in annual base salary to $1.0 million effective September 1, 2017 for Stephen Hemsley - SEC filing​

Aug 16 2017

UnitedHealth names Wichmann CEO, Hemsley executive chairman

NEW YORK UnitedHealth Group Inc said on Wednesday president David Wichmann will become the company's chief executive, succeeding Stephen Hemsley, who is moving to the newly created role of executive chairman after more than a decade at the helm of the largest U.S. health insurer.

Aug 16 2017

UPDATE 4-UnitedHealth names Wichmann CEO, Hemsley executive chairman

NEW YORK, Aug 16 UnitedHealth Group Inc said on Wednesday president David Wichmann will become the company's chief executive, succeeding Stephen Hemsley, who is moving to the newly created role of executive chairman after more than a decade at the helm of the largest U.S. health insurer.

Aug 16 2017

Competitors

Earnings vs. Estimates